Advos

New Haven, CT

News Category

NeuroThera Labs Launches Phase IIb Trial at Yale for Tourette Syndrome Treatment

NeuroThera Labs has initiated a Phase IIb clinical trial at Yale Child Study Center for SCI-110, a novel cannabinoid-based treatment for Tourette Synd...

August 5, 2026Read the full article →

NeuroThera Labs Initiates Phase IIb Trial for Tourette Syndrome Treatment at Hannover Medical School

NeuroThera Labs has started a Phase IIb clinical trial for its cannabinoid-based treatment SCI-110 in adults with Tourette Syndrome at Hannover Medica...

July 15, 2026Read the full article →

D-Wave Quantum Awarded $1.5M NSF Grant to Advance Fault-Tolerant Quantum Computing

D-Wave Quantum Inc. has been selected to receive a $1,566,250 grant from the U.S. National Science Foundation to support its role in the ERASE project...

July 7, 2026Read the full article →

D-Wave Quantum Awarded $1.5 Million NSF Grant for Fault-Tolerant Quantum Computing Research

D-Wave Quantum Inc. receives a $1.57 million NSF grant to contribute its dual-rail gate-model technology to the ERASE project, aiming to advance fault...

July 6, 2026Read the full article →